WEBVTT - Trump's NIH Cuts Send Shockwaves Through the Science World

0:00:00.360 --> 0:00:02.400
<v Speaker 1>Hey, Oddlots listeners, we're coming to DC.

0:00:02.840 --> 0:00:04.840
<v Speaker 2>We're finally doing it, Joe. It's going to be our

0:00:04.840 --> 0:00:09.200
<v Speaker 2>first live show in Washington, DC, our nation's capital. It's

0:00:09.240 --> 0:00:12.440
<v Speaker 2>also finally going to be the time where we actually

0:00:12.520 --> 0:00:13.640
<v Speaker 2>talk about the Jones Act.

0:00:13.880 --> 0:00:17.160
<v Speaker 1>Listen talk about doing the Jones Act episode of Odd

0:00:17.200 --> 0:00:19.880
<v Speaker 1>Lots for a long time, and it's become this recurring

0:00:19.920 --> 0:00:21.880
<v Speaker 1>joke that we've never done on But we're going to

0:00:21.920 --> 0:00:24.599
<v Speaker 1>do it in grand style because we're going to be

0:00:24.600 --> 0:00:27.240
<v Speaker 1>doing it live in DC and it's actually going to

0:00:27.240 --> 0:00:27.840
<v Speaker 1>be a debate.

0:00:28.240 --> 0:00:28.520
<v Speaker 3>Yeah.

0:00:28.640 --> 0:00:33.120
<v Speaker 2>So we have Sarah Fuentes from the Transportation Institute. She's

0:00:33.159 --> 0:00:35.080
<v Speaker 2>going to be taking the pro side, and we also

0:00:35.159 --> 0:00:38.600
<v Speaker 2>have Colin graybou of the Cato Institute. He'll be taking

0:00:38.880 --> 0:00:42.000
<v Speaker 2>the against side. It's going to be really interesting to

0:00:42.040 --> 0:00:43.880
<v Speaker 2>see how all of that shakes out.

0:00:43.960 --> 0:00:46.519
<v Speaker 1>In addition to that, we're going to be speaking with

0:00:46.720 --> 0:00:50.080
<v Speaker 1>Blair Levin, who was around during the telecom bubble, and

0:00:50.360 --> 0:00:53.440
<v Speaker 1>we have Andrew Ferguson, the new head of the FTC,

0:00:53.560 --> 0:00:55.320
<v Speaker 1>the one who's replaced Lina Kong. We're going to be

0:00:55.320 --> 0:00:57.920
<v Speaker 1>talking about mergers and acquisitions and all that stuff. So

0:00:58.240 --> 0:00:59.320
<v Speaker 1>it should be a really fun name.

0:00:59.520 --> 0:01:02.120
<v Speaker 2>If you want to come and join us for that evening,

0:01:02.240 --> 0:01:05.160
<v Speaker 2>it's going to be on March twelfth at the Miracle Theater.

0:01:05.440 --> 0:01:08.399
<v Speaker 2>Go to Bloomberg dot com forward slash odd Lots and

0:01:08.440 --> 0:01:10.839
<v Speaker 2>you can find the link to purchase tickets. We hope

0:01:10.840 --> 0:01:11.440
<v Speaker 2>to see you there.

0:01:14.319 --> 0:01:28.319
<v Speaker 4>Bloomberg Audio Studios, Podcasts, Radio News.

0:01:30.160 --> 0:01:33.839
<v Speaker 1>Hello and welcome to another episode of the Odd Lots podcast.

0:01:33.920 --> 0:01:35.440
<v Speaker 1>I'm Jill Wisenthal and.

0:01:35.400 --> 0:01:36.360
<v Speaker 2>I'm Tracy Alloway.

0:01:36.600 --> 0:01:40.600
<v Speaker 1>Tracy, we're recording this February twenty fifth, and we're just

0:01:40.640 --> 0:01:44.160
<v Speaker 1>a little bit over a month into the new Trump

0:01:44.240 --> 0:01:49.560
<v Speaker 1>administration and sitting aside how one views the long term

0:01:49.560 --> 0:01:53.800
<v Speaker 1>goals of the administration. From the outside, it's chattic, and

0:01:53.800 --> 0:01:56.480
<v Speaker 1>there have been a lot of cuts, and it doesn't

0:01:56.560 --> 0:01:59.600
<v Speaker 1>look like scalpel types of cuts. Many things have been

0:01:59.600 --> 0:02:03.360
<v Speaker 1>shut down or frozen completely in some respect, and you

0:02:03.440 --> 0:02:05.440
<v Speaker 1>see a lot of people talk about the implications of

0:02:05.560 --> 0:02:07.600
<v Speaker 1>these moves, but I find it hard to wrap my

0:02:07.600 --> 0:02:08.079
<v Speaker 1>head around.

0:02:08.400 --> 0:02:11.200
<v Speaker 2>There's a lot happening, that's for sure, and I think

0:02:11.240 --> 0:02:13.480
<v Speaker 2>one of the struggles of everyone who's trying to follow

0:02:13.520 --> 0:02:16.160
<v Speaker 2>this at the moment is that you have new executive

0:02:16.440 --> 0:02:19.960
<v Speaker 2>orders coming out almost daily. Then you have the legal

0:02:20.080 --> 0:02:23.440
<v Speaker 2>challenges to those, and then you have the administration itself

0:02:23.560 --> 0:02:28.560
<v Speaker 2>sometimes arguing within itself about whether or not certain orders

0:02:28.600 --> 0:02:32.080
<v Speaker 2>should be followed, certain emails should be replied to. It

0:02:32.120 --> 0:02:33.320
<v Speaker 2>does feel very chaotic.

0:02:33.760 --> 0:02:35.880
<v Speaker 1>One area that I think has caught a lot of

0:02:35.880 --> 0:02:41.040
<v Speaker 1>people's attention, in particular, has been immediate moves at the NIH,

0:02:41.120 --> 0:02:44.480
<v Speaker 1>the National Institute of Health. And there are multiple moving

0:02:44.760 --> 0:02:47.919
<v Speaker 1>parts here, but from what I've been understand that when

0:02:47.960 --> 0:02:50.760
<v Speaker 1>there are grants awarded, some of the money goes to

0:02:51.000 --> 0:02:53.720
<v Speaker 1>direct costs and some of it's indirect, and there has

0:02:53.720 --> 0:02:56.240
<v Speaker 1>been a change in what's allowed on the indirect And

0:02:56.280 --> 0:02:58.640
<v Speaker 1>then I've also seen, and it's almost hard to believe,

0:02:58.800 --> 0:03:01.280
<v Speaker 1>but I've now seen it in an places that there

0:03:01.320 --> 0:03:03.880
<v Speaker 1>have been like whole programs that got hit with an

0:03:03.880 --> 0:03:07.280
<v Speaker 1>immediate freeze, which I have to imagine in science creates

0:03:07.320 --> 0:03:10.640
<v Speaker 1>all sorts of problems imagined. There are lots of endeavors

0:03:10.639 --> 0:03:13.360
<v Speaker 1>that can't just be stop started on a switch, and

0:03:13.440 --> 0:03:17.200
<v Speaker 1>so understanding what's actually happening right now in science funding

0:03:17.520 --> 0:03:20.079
<v Speaker 1>and the implications of some of these moves is obviously

0:03:20.320 --> 0:03:24.239
<v Speaker 1>something we need to discuss, especially given the broader thing

0:03:24.320 --> 0:03:27.280
<v Speaker 1>of like we want to be, I think, a country

0:03:27.280 --> 0:03:29.120
<v Speaker 1>at the leading edge of science and technology.

0:03:29.280 --> 0:03:31.120
<v Speaker 2>Yeah, this is exactly the tension.

0:03:31.280 --> 0:03:31.799
<v Speaker 5>I think.

0:03:31.880 --> 0:03:35.080
<v Speaker 2>So even Elon Musk and Donald Trump will talk about

0:03:35.080 --> 0:03:38.120
<v Speaker 2>how important it is for the US to be technologically

0:03:38.160 --> 0:03:41.760
<v Speaker 2>advanced and to beat competitors like China. But at the

0:03:41.760 --> 0:03:44.840
<v Speaker 2>same time they're doing this, and I guess their argument

0:03:45.040 --> 0:03:49.160
<v Speaker 2>is that by capping some of the cost of research,

0:03:49.320 --> 0:03:51.920
<v Speaker 2>you might make it more efficient, you might make it

0:03:51.960 --> 0:03:56.600
<v Speaker 2>more monetizable, you might see more breakthroughs. But again, there

0:03:56.680 --> 0:04:00.720
<v Speaker 2>is this tension to the sledgehammer approach that we've seen,

0:04:01.200 --> 0:04:03.200
<v Speaker 2>where if you just put in a cap on something

0:04:03.240 --> 0:04:06.640
<v Speaker 2>like indirect funding, it can affect a bunch of research programs,

0:04:06.640 --> 0:04:08.560
<v Speaker 2>So we should talk about it. I also, I must

0:04:08.640 --> 0:04:12.040
<v Speaker 2>admit I don't know anything about NIH funding. It seems

0:04:12.160 --> 0:04:14.880
<v Speaker 2>very sprawling and very complicated, so I want to get

0:04:14.920 --> 0:04:15.720
<v Speaker 2>into that as well.

0:04:15.800 --> 0:04:17.640
<v Speaker 1>All right, well, I'm very excited to say we have

0:04:17.760 --> 0:04:21.480
<v Speaker 1>the perfect guest, someone who actually is a scientist in

0:04:21.600 --> 0:04:24.359
<v Speaker 1>the lab working on these things and has been talking

0:04:24.560 --> 0:04:27.839
<v Speaker 1>about the impact of the moves over the last several weeks.

0:04:28.040 --> 0:04:30.320
<v Speaker 1>Thrilled to bring on to the show. Carol Lebon, Professor

0:04:30.360 --> 0:04:35.200
<v Speaker 1>of Molecular Biosciences at Northwestern University, Professor Lebon, thank you

0:04:35.240 --> 0:04:37.600
<v Speaker 1>so much for coming on the out Lots podcast.

0:04:37.720 --> 0:04:38.559
<v Speaker 3>Happy to be here.

0:04:39.120 --> 0:04:40.880
<v Speaker 1>What's happened in the last month?

0:04:42.880 --> 0:04:44.200
<v Speaker 3>Why don't you ask a broad question?

0:04:44.279 --> 0:04:47.039
<v Speaker 2>So we need forty minutes for just answering that question.

0:04:47.520 --> 0:04:50.719
<v Speaker 3>Fine, Three major things have happened in the last months.

0:04:51.040 --> 0:04:54.159
<v Speaker 3>One is what you alluded to already, this attempt to

0:04:54.240 --> 0:04:57.640
<v Speaker 3>cap the indirect costs for grants at fifteen percent. And

0:04:57.680 --> 0:05:01.200
<v Speaker 3>I'm happy to go into that. Well, but you can

0:05:01.240 --> 0:05:03.719
<v Speaker 3>think about it if you pick any area of research

0:05:03.760 --> 0:05:07.279
<v Speaker 3>that you might care about. Let's say pediatric cancer, that

0:05:07.560 --> 0:05:10.520
<v Speaker 3>basically amounts to a fifteen to twenty percent decrease in

0:05:10.600 --> 0:05:14.160
<v Speaker 3>funding for studying those cancers. And this is an area

0:05:14.200 --> 0:05:17.680
<v Speaker 3>where NIH has made huge progress. So forty years ago,

0:05:18.200 --> 0:05:21.320
<v Speaker 3>if your child was diagnosed with cancer, there was less

0:05:21.360 --> 0:05:23.640
<v Speaker 3>of a sixty percent of those children that would still

0:05:23.680 --> 0:05:26.400
<v Speaker 3>be alive in five years. Today there's a ninety percent

0:05:26.440 --> 0:05:29.480
<v Speaker 3>survival rate. So I mean, these are impacts that are

0:05:29.480 --> 0:05:30.400
<v Speaker 3>going to be huge.

0:05:30.720 --> 0:05:32.920
<v Speaker 1>I'm gonna actually stop you right there because I think

0:05:32.960 --> 0:05:37.520
<v Speaker 1>this is important. There is science research that happens outside

0:05:37.520 --> 0:05:40.760
<v Speaker 1>of the NIH. When you look at that forty year history,

0:05:41.320 --> 0:05:44.800
<v Speaker 1>how do you draw the line for someone who'd you know,

0:05:44.920 --> 0:05:47.800
<v Speaker 1>people are aware of big pharma companies exist that this

0:05:47.920 --> 0:05:50.839
<v Speaker 1>is like the NIH should get credit for that progress.

0:05:51.400 --> 0:05:54.520
<v Speaker 3>So the NIH is really sort of two different systems.

0:05:54.720 --> 0:05:57.359
<v Speaker 3>They have an intramural system. So there are scientists running

0:05:57.400 --> 0:06:00.159
<v Speaker 3>laboratories at the NIH, and by the way, they have

0:06:00.279 --> 0:06:04.359
<v Speaker 3>not been exempt from these cuts to probationary people. I

0:06:04.480 --> 0:06:08.479
<v Speaker 3>know of young scientists who have started their independent laboratories

0:06:08.480 --> 0:06:10.560
<v Speaker 3>at the NIH in the last couple of years, who

0:06:10.720 --> 0:06:13.360
<v Speaker 3>least a week ago Saturday received an email at night

0:06:13.640 --> 0:06:16.560
<v Speaker 3>saying that they were terminated and that their access to

0:06:16.560 --> 0:06:20.560
<v Speaker 3>campus was gone. So there's intramural research, but the vast

0:06:20.720 --> 0:06:25.560
<v Speaker 3>majority of NIH grant funds go into their extramural program.

0:06:25.680 --> 0:06:29.120
<v Speaker 3>These are funds that go to grants at universities in

0:06:29.200 --> 0:06:34.440
<v Speaker 3>all fifty states, and they are incredibly important for all

0:06:34.560 --> 0:06:39.880
<v Speaker 3>levels of science. Basic research, translational research, clinical trials are

0:06:39.920 --> 0:06:42.800
<v Speaker 3>going on not at the NIH, but in Iowa and

0:06:43.000 --> 0:06:46.720
<v Speaker 3>in Ohio and in Florida, and so you know, it's

0:06:46.839 --> 0:06:50.240
<v Speaker 3>estimated that these grant monies that come to the universities

0:06:50.480 --> 0:06:55.240
<v Speaker 3>they support directly about four hundred thousand or more employees

0:06:55.440 --> 0:07:00.240
<v Speaker 3>across those fifty states. But also they drive more more

0:07:00.320 --> 0:07:04.039
<v Speaker 3>than ninety three billion dollars of economic activity each year.

0:07:04.279 --> 0:07:07.000
<v Speaker 3>And again that's across all fifty states. That's not staying

0:07:07.000 --> 0:07:10.800
<v Speaker 3>in Washington, DC. If there's an estimate that for every

0:07:10.920 --> 0:07:15.160
<v Speaker 3>dollar of NIH grant money that is granted, it generates

0:07:15.240 --> 0:07:18.760
<v Speaker 3>almost two dollars and fifty cents worth of economic activity.

0:07:19.840 --> 0:07:22.360
<v Speaker 2>Just to press on Joe's point, how do you actually

0:07:22.400 --> 0:07:26.320
<v Speaker 2>measure the success of NIH funding? Is it you produce

0:07:26.400 --> 0:07:30.120
<v Speaker 2>some new wonder drug that is monetizable and everyone starts

0:07:30.200 --> 0:07:33.480
<v Speaker 2>using it. Is it just the sort of nebulous concept

0:07:33.520 --> 0:07:37.440
<v Speaker 2>I guess of like advancing scientific research, how do you

0:07:37.560 --> 0:07:39.240
<v Speaker 2>judge the success and efficacy?

0:07:39.760 --> 0:07:41.320
<v Speaker 3>So I think that you can look at that on

0:07:41.360 --> 0:07:45.040
<v Speaker 3>two levels. So there are the studies that are translational

0:07:45.120 --> 0:07:48.760
<v Speaker 3>studies that immediately impact human health, and those are very,

0:07:48.880 --> 0:07:51.920
<v Speaker 3>very important, but just as important as the kind of

0:07:51.960 --> 0:07:55.480
<v Speaker 3>research that the general public sometimes has trouble wrapping their

0:07:55.520 --> 0:08:00.240
<v Speaker 3>heads around because you don't necessarily see an immediate as

0:08:00.360 --> 0:08:03.680
<v Speaker 3>from that research in human health. But most of the

0:08:03.720 --> 0:08:07.200
<v Speaker 3>advances that we see today that are being translated and

0:08:07.200 --> 0:08:10.280
<v Speaker 3>are really making a direct effect on human health. They

0:08:10.320 --> 0:08:13.640
<v Speaker 3>stem from studies that were done ten or even twenty

0:08:13.720 --> 0:08:17.119
<v Speaker 3>years ago that were foundational that at the time, again

0:08:17.240 --> 0:08:20.920
<v Speaker 3>didn't This is called discovery based science or basic science

0:08:21.000 --> 0:08:25.480
<v Speaker 3>or fundamental research. But it's these foundations that are built

0:08:25.520 --> 0:08:28.760
<v Speaker 3>on in the more clinical studies and also in industry,

0:08:28.800 --> 0:08:32.040
<v Speaker 3>in the pharmaceutical industry and biotech, they are building on

0:08:32.080 --> 0:08:35.160
<v Speaker 3>these basic discoveries that were funded by the NIH. I

0:08:35.200 --> 0:08:38.600
<v Speaker 3>can give you one really cool example. So you've got

0:08:38.640 --> 0:08:41.600
<v Speaker 3>to have heard of ozenpic right, the semaglut hide that's

0:08:41.640 --> 0:08:46.559
<v Speaker 3>everywhere these days. Did you know that that came from research,

0:08:46.760 --> 0:08:50.400
<v Speaker 3>very basic research that was done ages ago on a

0:08:50.520 --> 0:08:54.040
<v Speaker 3>venomous lizard called a gilla monster. A gila monster at

0:08:54.040 --> 0:08:56.960
<v Speaker 3>this Scala monster is native to the southwest of the US,

0:08:57.400 --> 0:09:01.280
<v Speaker 3>and people noticed that. Scientists noticed that it had the

0:09:01.360 --> 0:09:05.559
<v Speaker 3>ability to fast for an incredibly long period of time,

0:09:06.040 --> 0:09:09.680
<v Speaker 3>so wanting to understand the biological mechanisms of how it did,

0:09:09.720 --> 0:09:13.600
<v Speaker 3>that led them to isolate from the saliva of a

0:09:13.720 --> 0:09:17.679
<v Speaker 3>Glian monster. This what would eventually become ozenpec.

0:09:18.280 --> 0:09:21.320
<v Speaker 1>Talk to us about the math of direct versus indirect costs,

0:09:21.320 --> 0:09:23.440
<v Speaker 1>because I think this is just something that was in

0:09:23.480 --> 0:09:26.640
<v Speaker 1>the headline of the announcement. And I don't think I

0:09:26.720 --> 0:09:30.360
<v Speaker 1>really have a concrete understanding of what the difference is,

0:09:30.559 --> 0:09:34.000
<v Speaker 1>why there is this distinct allocation. What do you walk

0:09:34.080 --> 0:09:36.480
<v Speaker 1>us through a year ago or just in the up

0:09:36.600 --> 0:09:40.080
<v Speaker 1>until recently, what this allocation was all about.

0:09:40.200 --> 0:09:43.360
<v Speaker 3>So every grant that goes to let's say Northwestern where

0:09:43.360 --> 0:09:46.160
<v Speaker 3>I am, has two components to it. Direct costs that

0:09:46.240 --> 0:09:50.000
<v Speaker 3>come directly to my research laboratory, and indirect costs that

0:09:50.040 --> 0:09:53.520
<v Speaker 3>are used to support my research. So a lab like

0:09:53.600 --> 0:09:57.480
<v Speaker 3>mine is analogous to running a small business. So let's

0:09:57.520 --> 0:10:00.520
<v Speaker 3>say that business as a restaurant. Ye costs or the

0:10:00.520 --> 0:10:03.440
<v Speaker 3>restaurant would be the food, the cooks, and the servers.

0:10:04.040 --> 0:10:06.439
<v Speaker 3>But there are other costs to running a restaurant business.

0:10:06.480 --> 0:10:10.120
<v Speaker 3>You have inventory and purchasing and upkeep the kitchen equipment

0:10:10.200 --> 0:10:13.000
<v Speaker 3>and the building, et cetera. And so the restaurant can't

0:10:13.080 --> 0:10:15.400
<v Speaker 3>run without those other things. It can't exist with just

0:10:15.520 --> 0:10:18.040
<v Speaker 3>the food, the cooks, and the servers. And so for

0:10:18.120 --> 0:10:22.080
<v Speaker 3>a research lab like mine, the direct costs are the

0:10:22.160 --> 0:10:26.199
<v Speaker 3>chemicals and the reagents and the salaries of the scientists

0:10:26.200 --> 0:10:29.640
<v Speaker 3>who are carrying out the studies. But there's also indirect costs,

0:10:29.880 --> 0:10:34.040
<v Speaker 3>and those again include maintenance and replacement of equipment, ordering, bookkeeping,

0:10:34.200 --> 0:10:38.720
<v Speaker 3>handling hazardous waste, compliance with government regulations, all of which

0:10:38.720 --> 0:10:42.160
<v Speaker 3>are absolutely essential to doing the research. And the reason

0:10:42.280 --> 0:10:45.240
<v Speaker 3>it gets separated out like this is actually to save

0:10:45.400 --> 0:10:49.120
<v Speaker 3>money because while the direct costs are specific to my

0:10:49.240 --> 0:10:54.320
<v Speaker 3>particular research, most of those indirect costs are for most,

0:10:54.400 --> 0:10:57.880
<v Speaker 3>if not all, research labs at a given university, and

0:10:57.920 --> 0:11:01.680
<v Speaker 3>so you get economies of scale by lumping those together.

0:11:01.760 --> 0:11:02.600
<v Speaker 3>Does that make sense?

0:11:02.840 --> 0:11:05.480
<v Speaker 2>Yeah, So going back to your restaurant analogy, I guess

0:11:05.480 --> 0:11:08.160
<v Speaker 2>it's kind of like your funding of food court, right,

0:11:08.240 --> 0:11:12.080
<v Speaker 2>So each individual restaurant within a food court might have

0:11:12.200 --> 0:11:14.800
<v Speaker 2>their own direct costs, but then the cost of actually

0:11:14.880 --> 0:11:18.200
<v Speaker 2>maintaining the space, renting out the space is sort of

0:11:18.320 --> 0:11:20.600
<v Speaker 2>shared by everyone doing different things.

0:11:21.000 --> 0:11:23.400
<v Speaker 3>Sure, I think that's a great advance on the analogy,

0:11:23.440 --> 0:11:26.720
<v Speaker 3>and it would be particularly so if they had a pooled,

0:11:26.880 --> 0:11:29.320
<v Speaker 3>let's say, central building, so that they didn't each have

0:11:29.440 --> 0:11:31.359
<v Speaker 3>to handle the finances individually.

0:11:32.040 --> 0:11:35.480
<v Speaker 2>So one thing that I was wondering is how the

0:11:36.240 --> 0:11:40.720
<v Speaker 2>NIH cap on indirect funding currently or I guess up

0:11:40.800 --> 0:11:43.920
<v Speaker 2>until a month or two ago, actually compares with other

0:11:44.000 --> 0:11:49.160
<v Speaker 2>medical research organizations because I'm thinking specifically about organizations like

0:11:49.200 --> 0:11:51.640
<v Speaker 2>the Gates Foundation, and I think in the announcement that

0:11:51.720 --> 0:11:56.319
<v Speaker 2>NIH talked about aligning with other types of research organizations

0:11:56.440 --> 0:12:01.080
<v Speaker 2>like the John Templeton Foundation. So how do private research

0:12:01.320 --> 0:12:05.840
<v Speaker 2>organizations manage to keep their own indirect costs down? And

0:12:06.000 --> 0:12:10.160
<v Speaker 2>why do their indirect costs seem lower than the nihs?

0:12:10.480 --> 0:12:12.760
<v Speaker 3>Oh, I mean they are lower, and there are in

0:12:12.800 --> 0:12:16.800
<v Speaker 3>fact some types of small foundations that have no indirect costs.

0:12:17.160 --> 0:12:19.360
<v Speaker 3>I remember back when I was a graduate student at Harvard.

0:12:19.440 --> 0:12:23.040
<v Speaker 3>Harvard wanted to stop letting their researchers take those grants

0:12:23.160 --> 0:12:26.880
<v Speaker 3>because they were not paying for the other real costs

0:12:26.880 --> 0:12:30.520
<v Speaker 3>of doing research. But in general, over time, what's come

0:12:30.559 --> 0:12:34.160
<v Speaker 3>out of it is in the research ecosystem, universities admit

0:12:34.640 --> 0:12:38.240
<v Speaker 3>that these smaller foundations and even something like the Gates Foundation,

0:12:38.720 --> 0:12:41.760
<v Speaker 3>you know, they're directing money at very specific things, and

0:12:42.040 --> 0:12:45.720
<v Speaker 3>they can do more with their work if they lean

0:12:45.800 --> 0:12:49.200
<v Speaker 3>on the NIH and universities for covering more of those

0:12:49.240 --> 0:12:52.280
<v Speaker 3>indirect costs. So they don't cover the indirect costs, it's

0:12:52.320 --> 0:12:55.120
<v Speaker 3>just that it's understood that they can't.

0:12:55.520 --> 0:12:59.200
<v Speaker 1>So your assertion here is that what appears to be

0:12:59.360 --> 0:13:05.040
<v Speaker 1>a finance mechanism with lower indirect costs is capable of existing.

0:13:05.600 --> 0:13:08.160
<v Speaker 1>Because I don't know if free writing is the right word,

0:13:08.240 --> 0:13:11.640
<v Speaker 1>but because there is also the indirect costs that come

0:13:11.760 --> 0:13:15.160
<v Speaker 1>from the NIH too aligned or the same labs.

0:13:15.559 --> 0:13:22.640
<v Speaker 3>Absolutely, they're like a lost leader.

0:13:32.760 --> 0:13:35.880
<v Speaker 1>So one of the arguments is that a lot of

0:13:36.080 --> 0:13:42.640
<v Speaker 1>NIH funding goes to a handful of extremely well endowed universities.

0:13:42.720 --> 0:13:46.880
<v Speaker 1>It's a skewed That also is something you hear a lot,

0:13:46.920 --> 0:13:50.079
<v Speaker 1>including from people academia, that there is a tremendous amount

0:13:50.160 --> 0:13:54.320
<v Speaker 1>of bureaucratic bloat that exists. And I think, setting aside

0:13:54.440 --> 0:13:57.199
<v Speaker 1>the science, it does not surprise me that the current

0:13:57.240 --> 0:14:02.959
<v Speaker 1>administration wants to take aim at bureaucratic bloat within America's universities,

0:14:03.080 --> 0:14:06.880
<v Speaker 1>et cetera. Why shouldn't we be skeptical of the degree

0:14:06.880 --> 0:14:09.440
<v Speaker 1>of costs that these labs have born.

0:14:09.960 --> 0:14:12.320
<v Speaker 3>I mean, I think you shouldn't be skeptical because these

0:14:12.400 --> 0:14:17.960
<v Speaker 3>are negotiated between Health and Human Services and the universities

0:14:18.240 --> 0:14:21.320
<v Speaker 3>through a very thorough process where they sit down and

0:14:21.360 --> 0:14:23.880
<v Speaker 3>really have to lay out what the costs are and

0:14:23.960 --> 0:14:26.680
<v Speaker 3>show proof that that's what the costs are. So this

0:14:26.800 --> 0:14:29.240
<v Speaker 3>isn't somebody picking the number out of the air. This

0:14:29.320 --> 0:14:32.600
<v Speaker 3>has been the result of negotiations to really figure out

0:14:32.640 --> 0:14:35.200
<v Speaker 3>what the costs are. And you know, most university would

0:14:35.200 --> 0:14:38.440
<v Speaker 3>tell you that even the negotiated interrect cost raise don't

0:14:38.440 --> 0:14:40.160
<v Speaker 3>cover all the costs of research.

0:14:40.840 --> 0:14:43.640
<v Speaker 2>This is a very wide ranging question. But going back

0:14:43.680 --> 0:14:47.160
<v Speaker 2>to Joe's point about the administrative burden, could you maybe

0:14:47.320 --> 0:14:51.360
<v Speaker 2>walk us through the process of getting an NAH grant, Like,

0:14:51.400 --> 0:14:53.640
<v Speaker 2>how does it actually work, how long does it take?

0:14:53.920 --> 0:14:55.840
<v Speaker 2>How many steps do you have to go through?

0:14:56.360 --> 0:15:01.200
<v Speaker 3>Yeah, so NIH runs three funding cycles, each of them

0:15:01.440 --> 0:15:04.600
<v Speaker 3>take more than half a year to complete, almost three

0:15:04.680 --> 0:15:07.280
<v Speaker 3>quarters of a year. So basically, there will be one

0:15:07.360 --> 0:15:11.360
<v Speaker 3>date where grants are submitted, another date where grants are

0:15:11.760 --> 0:15:14.560
<v Speaker 3>reviewed by a panel of experts from around the country,

0:15:14.640 --> 0:15:17.240
<v Speaker 3>usually a panel of twenty five to thirty scientists with

0:15:17.280 --> 0:15:20.280
<v Speaker 3>subject matter expertise in the area of the grants, and

0:15:20.320 --> 0:15:23.240
<v Speaker 3>those are called study sections. And then finally they'll be

0:15:23.520 --> 0:15:28.120
<v Speaker 3>reviewed by an advisory council that will basically okay grants

0:15:28.120 --> 0:15:31.200
<v Speaker 3>for funding. So here's an example. I have a really

0:15:31.240 --> 0:15:35.000
<v Speaker 3>talented post doctoral fellow working in my research group who

0:15:35.320 --> 0:15:39.000
<v Speaker 3>applied for a career transition award back in the summer.

0:15:39.520 --> 0:15:43.120
<v Speaker 3>His grant was reviewed in October by a study section.

0:15:43.560 --> 0:15:46.440
<v Speaker 3>It got a phenomenal score that should have been funded.

0:15:46.920 --> 0:15:49.120
<v Speaker 3>His council was supposed to meet at the beginning of

0:15:49.120 --> 0:15:52.680
<v Speaker 3>this month in February, but because no study sections or

0:15:52.720 --> 0:15:55.400
<v Speaker 3>councils have been allowed to meet, his grant can't be

0:15:55.440 --> 0:15:58.440
<v Speaker 3>approved for funding. So there are three of those cycles

0:15:58.480 --> 0:16:01.240
<v Speaker 3>a year, and right now, I mean, I'm not sure

0:16:01.240 --> 0:16:03.960
<v Speaker 3>that if your listeners are aware of this, but besides

0:16:04.000 --> 0:16:06.320
<v Speaker 3>the kinds of things that we're talking about with indirect

0:16:06.320 --> 0:16:12.000
<v Speaker 3>costs and direct costs, HHS has blocked NIH from posting

0:16:12.200 --> 0:16:16.200
<v Speaker 3>in the Federal Register. And why that matters is in

0:16:16.320 --> 0:16:18.920
<v Speaker 3>order to hold one of these study sections, these grant

0:16:18.920 --> 0:16:22.480
<v Speaker 3>review sections, or hold one of these advisory councils, they

0:16:22.520 --> 0:16:24.920
<v Speaker 3>have to be posted in the Federal Register at least

0:16:24.920 --> 0:16:28.680
<v Speaker 3>fifteen days ahead by law. So when a judge put

0:16:28.680 --> 0:16:33.080
<v Speaker 3>a restraining order on the freeze to grants, HHS got

0:16:33.080 --> 0:16:37.160
<v Speaker 3>around this bureaucratically by just simply not letting NIH submit

0:16:37.240 --> 0:16:40.360
<v Speaker 3>those notices. So the whole system has been ground to

0:16:40.400 --> 0:16:43.960
<v Speaker 3>a halt. Grants that were reviewed like my postdocs last

0:16:43.960 --> 0:16:47.280
<v Speaker 3>fall can't get approved at council grants that should have

0:16:47.320 --> 0:16:50.560
<v Speaker 3>been reviewed this month can't be reviewed, and who knows

0:16:50.600 --> 0:16:53.440
<v Speaker 3>whether their councils will meet coming in May when they should.

0:16:54.040 --> 0:16:56.880
<v Speaker 3>So right now, labs are really in sort of an

0:16:56.880 --> 0:17:00.280
<v Speaker 3>existential crisis. I mean so again, going back to this

0:17:00.560 --> 0:17:04.760
<v Speaker 3>small business model, labs are businesses that run on very

0:17:04.840 --> 0:17:08.399
<v Speaker 3>tight margins. And so if I'm going to be running

0:17:08.400 --> 0:17:10.840
<v Speaker 3>my laboratory on one of these NIH grants, which let's

0:17:10.880 --> 0:17:13.960
<v Speaker 3>say is four years long, in year three, I would

0:17:14.000 --> 0:17:17.920
<v Speaker 3>be applying for a renewal of that grant to continue

0:17:17.960 --> 0:17:21.760
<v Speaker 3>that research, and remember research that the NIH has already

0:17:21.800 --> 0:17:25.920
<v Speaker 3>invested in. If that grant can't get reviewed or funded,

0:17:26.400 --> 0:17:28.760
<v Speaker 3>then I'm turning around to the people in my lab

0:17:28.800 --> 0:17:31.119
<v Speaker 3>and saying, I don't want to have to do this,

0:17:31.280 --> 0:17:33.280
<v Speaker 3>but I'm going to have to let you go. So

0:17:33.359 --> 0:17:35.199
<v Speaker 3>not only is that a real cost in terms of

0:17:35.320 --> 0:17:38.560
<v Speaker 3>jobs for people who are again experts in what they're doing,

0:17:39.040 --> 0:17:43.199
<v Speaker 3>but you're damaging research that you've already invested in. The

0:17:43.240 --> 0:17:46.359
<v Speaker 3>whole thing is kind of senseless. That's certainly not government efficiency.

0:17:46.680 --> 0:17:49.640
<v Speaker 1>Can you talk more about what's being frozen right now?

0:17:49.680 --> 0:17:52.600
<v Speaker 1>So you've just described the stopping of the review process.

0:17:52.640 --> 0:17:55.399
<v Speaker 1>So Theoretically, if this freeze is in place by the

0:17:55.400 --> 0:17:58.879
<v Speaker 1>time you need your next transfer funding and it can't happen,

0:17:59.080 --> 0:18:03.280
<v Speaker 1>then you could have what's happening operationally in labs that

0:18:03.359 --> 0:18:06.040
<v Speaker 1>you know of right now as a result of the

0:18:06.080 --> 0:18:10.080
<v Speaker 1>overall freeze. Are there specific trials or tests or I

0:18:10.080 --> 0:18:13.280
<v Speaker 1>guess experiments is what a lay person might call them,

0:18:13.560 --> 0:18:16.159
<v Speaker 1>that had been going on in January that aren't happening

0:18:16.200 --> 0:18:16.600
<v Speaker 1>right now.

0:18:17.240 --> 0:18:19.840
<v Speaker 3>So I think there are some clinical trials out of

0:18:19.920 --> 0:18:23.040
<v Speaker 3>NIHS that have been affected directly. For most of us,

0:18:23.320 --> 0:18:26.560
<v Speaker 3>it's damaging things, but we could still pull back from

0:18:26.600 --> 0:18:30.720
<v Speaker 3>it being absolutely disastrous if things get turned around very

0:18:30.880 --> 0:18:35.200
<v Speaker 3>very soon. But otherwise, the layoffs are going to include

0:18:35.359 --> 0:18:38.600
<v Speaker 3>people who take care of research animals. It's going to

0:18:38.640 --> 0:18:42.040
<v Speaker 3>include the people that make sure that hazardous waste is

0:18:42.080 --> 0:18:45.280
<v Speaker 3>supposed of safely. And right now it really depends on

0:18:45.760 --> 0:18:50.720
<v Speaker 3>each university. A lot of universities have begun to either

0:18:51.080 --> 0:18:55.160
<v Speaker 3>rescind offers for graduate students for the coming fall, or

0:18:55.400 --> 0:18:58.760
<v Speaker 3>basically decide not to have the next class of graduate

0:18:58.800 --> 0:19:01.280
<v Speaker 3>students who are cut it down by twenty to fifty percent.

0:19:01.920 --> 0:19:04.399
<v Speaker 3>And I think this is something it's important to bring up.

0:19:04.640 --> 0:19:08.840
<v Speaker 3>So NIH research really does three things, right. It funds

0:19:08.920 --> 0:19:12.320
<v Speaker 3>the science that we've been talking about, so making drugs

0:19:12.400 --> 0:19:18.600
<v Speaker 3>like ozienpic or pediatric cancer research. It funds money in

0:19:18.680 --> 0:19:21.840
<v Speaker 3>the economy, as I mentioned, so hundreds of thousands of jobs,

0:19:22.119 --> 0:19:25.399
<v Speaker 3>ninety three billion dollars a year in economic activity. But

0:19:25.480 --> 0:19:28.200
<v Speaker 3>the other thing it does is to train the next

0:19:28.240 --> 0:19:32.359
<v Speaker 3>generation of research scientists. And I can tell you that

0:19:32.440 --> 0:19:35.840
<v Speaker 3>the train needs right now. Graduate students and postdoctoral fellows

0:19:36.119 --> 0:19:39.520
<v Speaker 3>are completely scared and demoralized and wondering whether there is

0:19:39.560 --> 0:19:42.960
<v Speaker 3>a future for them in science. And if we lose

0:19:43.000 --> 0:19:45.800
<v Speaker 3>the next generation of scientific researchers, it's not just going

0:19:45.840 --> 0:19:49.679
<v Speaker 3>to affect academic research. We train the workforce for the

0:19:49.680 --> 0:19:53.920
<v Speaker 3>pharmaceutical industry and the biotech industry. This is going to

0:19:53.960 --> 0:19:57.879
<v Speaker 3>decimate US scientific biomedical research broadly written.

0:19:58.640 --> 0:20:01.560
<v Speaker 2>So just on that note, one thing you hear from

0:20:01.640 --> 0:20:04.760
<v Speaker 2>the Trump administration continuously is this idea that we need

0:20:04.800 --> 0:20:07.280
<v Speaker 2>to compete with China. And it's certainly true when it

0:20:07.320 --> 0:20:12.439
<v Speaker 2>comes to electronics technology like semiconductors, And they say also

0:20:12.640 --> 0:20:15.440
<v Speaker 2>in the realm of scientific funding, can you maybe talk

0:20:15.480 --> 0:20:19.360
<v Speaker 2>a little bit about how the Chinese research model stacks

0:20:19.440 --> 0:20:22.600
<v Speaker 2>up against the US research model, and I guess how

0:20:22.640 --> 0:20:26.520
<v Speaker 2>much competition there is currently between the two countries for

0:20:26.680 --> 0:20:28.320
<v Speaker 2>that younger generation of talent.

0:20:28.800 --> 0:20:32.480
<v Speaker 3>Yeah. No, absolutely, As I'm sure you're probably aware, federal

0:20:32.520 --> 0:20:35.639
<v Speaker 3>investment in science like at NIH and the National Science

0:20:35.640 --> 0:20:39.440
<v Speaker 3>Foundation after World War Two was what drove the US's

0:20:39.760 --> 0:20:43.280
<v Speaker 3>enormous growth in the fifties and sixties and really boosted

0:20:43.320 --> 0:20:46.560
<v Speaker 3>America to the forefront of the world in technology development

0:20:46.640 --> 0:20:50.439
<v Speaker 3>in science, and we barely keep pace. I mean, to

0:20:50.480 --> 0:20:53.000
<v Speaker 3>say that we spend too much money on science is

0:20:53.080 --> 0:20:56.280
<v Speaker 3>so far from being true that it's crazy. On the

0:20:56.280 --> 0:21:01.000
<v Speaker 3>other hand, China recognizes what these investments do, and they

0:21:01.000 --> 0:21:04.439
<v Speaker 3>have been upping and upping the kinds of investments that

0:21:04.520 --> 0:21:09.679
<v Speaker 3>they make in biotechnology and another technology because that is

0:21:09.720 --> 0:21:13.320
<v Speaker 3>what's going to drive the economic growth of the future.

0:21:13.880 --> 0:21:18.320
<v Speaker 3>The investments that US has made in science today have

0:21:18.640 --> 0:21:24.400
<v Speaker 3>driven the formation of entire industries, not just innovations in medicine,

0:21:24.440 --> 0:21:27.679
<v Speaker 3>but also in engineering and technology. We are going to

0:21:27.720 --> 0:21:28.760
<v Speaker 3>lose that leadership.

0:21:29.359 --> 0:21:33.840
<v Speaker 1>You've given these examples of talented postdocs being unsure that

0:21:33.880 --> 0:21:36.879
<v Speaker 1>they're going to get their funding, or the prospect that

0:21:36.960 --> 0:21:40.479
<v Speaker 1>the next generation of talent who will go into private

0:21:40.520 --> 0:21:43.520
<v Speaker 1>sector labs is going to be devastated because their education

0:21:43.640 --> 0:21:47.360
<v Speaker 1>trajectory is off. One of the arguments for NIH reform

0:21:47.640 --> 0:21:50.240
<v Speaker 1>is that a lot of NIH grants actually go to

0:21:50.840 --> 0:21:54.560
<v Speaker 1>established professionals, that there is this hierarchy that a lot

0:21:54.880 --> 0:21:57.320
<v Speaker 1>it's very hard or very rare to get grants for

0:21:57.480 --> 0:22:03.159
<v Speaker 1>people under forty. Setting aside the Trump elon reforms, do

0:22:03.240 --> 0:22:06.960
<v Speaker 1>you believe that there are flaws within the existing NIH

0:22:07.040 --> 0:22:10.880
<v Speaker 1>regime causing money to not go into the most promising areas.

0:22:11.080 --> 0:22:14.960
<v Speaker 3>So I would take issue with what's going on being

0:22:15.359 --> 0:22:18.679
<v Speaker 3>termed that. But Okay, the problem is that there's not

0:22:18.920 --> 0:22:22.520
<v Speaker 3>enough money in the system. And so those grant cycles

0:22:22.520 --> 0:22:26.200
<v Speaker 3>that I just mentioned, so one of the study sections

0:22:26.640 --> 0:22:31.760
<v Speaker 3>is going to be evaluating many, many dozens of grants

0:22:31.800 --> 0:22:34.240
<v Speaker 3>in each cycle, and then there are many study sections

0:22:34.280 --> 0:22:38.880
<v Speaker 3>that are evaluating different areas of science. At current funding levels,

0:22:39.640 --> 0:22:42.159
<v Speaker 3>less than ten percent of those grants are going to

0:22:42.160 --> 0:22:44.600
<v Speaker 3>be able to be funded. Where is the line that

0:22:44.640 --> 0:22:48.160
<v Speaker 3>I could draw where I could clearly say that these

0:22:48.200 --> 0:22:52.359
<v Speaker 3>ones are absolutely should be funded and these ones maybe

0:22:52.400 --> 0:22:55.200
<v Speaker 3>need more work or more thought. That line is more

0:22:55.320 --> 0:22:58.200
<v Speaker 3>around the twenty five to thirty percent. So we are

0:22:58.320 --> 0:23:01.640
<v Speaker 3>really underfunding research and you're right. When you are under

0:23:01.680 --> 0:23:04.360
<v Speaker 3>funding research, there is going to be, if you will,

0:23:04.359 --> 0:23:09.720
<v Speaker 3>a competitive advantage to establish researchers versus your researchers. But

0:23:09.760 --> 0:23:12.840
<v Speaker 3>the NIH recognizes that, and so they have put in

0:23:12.920 --> 0:23:18.479
<v Speaker 3>place a number of different mechanisms to try to alleviate that.

0:23:19.040 --> 0:23:23.159
<v Speaker 3>So there are score boosts for early career investigators that

0:23:23.359 --> 0:23:26.240
<v Speaker 3>help more of them get funded. They are special granting

0:23:26.320 --> 0:23:29.640
<v Speaker 3>programs that are aimed at those early career investigators. So,

0:23:29.720 --> 0:23:32.240
<v Speaker 3>I mean, one of the things about NIH is that

0:23:32.560 --> 0:23:37.520
<v Speaker 3>it's really conscientious about trying to course correct. They are

0:23:37.600 --> 0:23:42.440
<v Speaker 3>constantly looking at what they're doing and what the outcomes are,

0:23:43.000 --> 0:23:48.679
<v Speaker 3>and then consulting with the broader scientific community about where

0:23:48.720 --> 0:23:52.160
<v Speaker 3>they could find efficiencies or how they could solve particular problems.

0:23:52.480 --> 0:23:54.000
<v Speaker 3>It's not like all of this is going on in

0:23:54.040 --> 0:23:55.680
<v Speaker 3>a vacuum and nobody's paying attention.

0:23:56.000 --> 0:23:57.359
<v Speaker 1>That makes a lot of sense to me. I'm just

0:23:57.400 --> 0:24:01.960
<v Speaker 1>looking at stats. The median age for researcher designated an

0:24:02.000 --> 0:24:04.840
<v Speaker 1>NIH award for the first time had increased since nineteen

0:24:04.920 --> 0:24:08.560
<v Speaker 1>ninety five and is now, according to something that was

0:24:08.600 --> 0:24:13.600
<v Speaker 1>reported in twenty twenty one, over forty years old. Like government,

0:24:14.160 --> 0:24:17.520
<v Speaker 1>corporate prosties whatever. There's always, as you say, there's course correcting,

0:24:17.560 --> 0:24:20.600
<v Speaker 1>there's awareness of the issues, but awareness is not the

0:24:20.600 --> 0:24:23.639
<v Speaker 1>same thing as addressing them. And I'm just trying to

0:24:23.720 --> 0:24:27.080
<v Speaker 1>press on whether there are reasons to be skeptical about

0:24:27.160 --> 0:24:30.439
<v Speaker 1>the efficacy of the existing system or the ability of

0:24:30.440 --> 0:24:34.199
<v Speaker 1>the existing system to course correct or is this not

0:24:34.240 --> 0:24:35.920
<v Speaker 1>a number that we should care about at all? Does

0:24:35.960 --> 0:24:38.879
<v Speaker 1>that not mean anything that the average age of a

0:24:38.920 --> 0:24:42.000
<v Speaker 1>first time awardy has gone up. Maybe that's not necessarily

0:24:42.040 --> 0:24:42.480
<v Speaker 1>a bad thing.

0:24:42.920 --> 0:24:45.160
<v Speaker 3>Yeah, So, you know, one thing you can say about

0:24:45.160 --> 0:24:47.840
<v Speaker 3>almost anything this large is it's the best flawed system

0:24:47.880 --> 0:24:51.879
<v Speaker 3>that we have. The US scientific research enterprise is the

0:24:52.000 --> 0:24:55.560
<v Speaker 3>envy of the entire world, hands down. The reason for

0:24:55.640 --> 0:24:59.199
<v Speaker 3>the increase in age has nothing really to do with

0:24:59.240 --> 0:25:03.240
<v Speaker 3>the NIH and so that's more on science and scientists.

0:25:03.240 --> 0:25:07.200
<v Speaker 3>To some extent. The time to degree for graduate students

0:25:07.200 --> 0:25:09.439
<v Speaker 3>has been creeping up, how long it takes them to

0:25:09.440 --> 0:25:13.400
<v Speaker 3>earn their PhD, and also the time that faculty spend

0:25:13.400 --> 0:25:16.120
<v Speaker 3>as postdoctoral fellows. And you know, when I was first

0:25:16.119 --> 0:25:18.840
<v Speaker 3>starting out as a graduate student in the nineties, there

0:25:18.880 --> 0:25:21.600
<v Speaker 3>were people who were hired into faculty positions that never

0:25:21.640 --> 0:25:26.240
<v Speaker 3>did postdoctoral fellows. Then that became almost non existent, and

0:25:26.280 --> 0:25:29.720
<v Speaker 3>now there are some programs like the Whitehead Fellows where

0:25:29.760 --> 0:25:34.560
<v Speaker 3>you have mentored postdoc positions where they are independent faculty

0:25:34.720 --> 0:25:37.040
<v Speaker 3>member like people, but with a little bit more safety

0:25:37.080 --> 0:25:40.199
<v Speaker 3>net than a typical assistant professor would have. And so

0:25:40.680 --> 0:25:42.879
<v Speaker 3>you know, I'm going to swing back to those people

0:25:42.920 --> 0:25:47.080
<v Speaker 3>that get fired from their laboratories at THEIH two weeks ago.

0:25:47.760 --> 0:25:51.520
<v Speaker 3>So each one of those people will have spent more

0:25:51.600 --> 0:25:54.520
<v Speaker 3>than ten years training for their jobs, generally more than

0:25:54.560 --> 0:25:59.520
<v Speaker 3>twelve years training. But between graduate school and their postdoctoral fellowship,

0:26:00.080 --> 0:26:04.320
<v Speaker 3>each one of those people was almost certainly supported by

0:26:04.600 --> 0:26:09.159
<v Speaker 3>NIH funding through those dozen years, whether it be independent

0:26:09.200 --> 0:26:14.960
<v Speaker 3>fellowships to them personally or funding from their pi's research grants.

0:26:15.520 --> 0:26:18.760
<v Speaker 3>So these are people who the US has already made

0:26:18.960 --> 0:26:24.200
<v Speaker 3>an enormous investment in and they were successful at getting

0:26:24.560 --> 0:26:27.960
<v Speaker 3>research laboratory positions at one of the top places in

0:26:28.000 --> 0:26:30.600
<v Speaker 3>the world, the NIH. So these are the best of

0:26:30.640 --> 0:26:33.560
<v Speaker 3>the best, and we just fired them by email on

0:26:33.600 --> 0:26:36.800
<v Speaker 3>a Saturday night. That's a waste of all that money

0:26:36.800 --> 0:26:39.679
<v Speaker 3>that was spent training those people and the research they

0:26:39.680 --> 0:26:40.080
<v Speaker 3>were doing.

0:26:55.359 --> 0:26:58.560
<v Speaker 2>You mentioned slim profit margins earlier, and I think This

0:26:58.760 --> 0:27:00.639
<v Speaker 2>is one of the things that a lot of people

0:27:00.760 --> 0:27:04.200
<v Speaker 2>struggle with when they talk about public funding for research

0:27:04.359 --> 0:27:08.639
<v Speaker 2>at elite universities, in particular, because you see numbers like,

0:27:08.720 --> 0:27:12.240
<v Speaker 2>you know, the Harvard Endowment has more than fifty billion dollars,

0:27:12.280 --> 0:27:15.600
<v Speaker 2>and there are other universities out there with even more.

0:27:16.119 --> 0:27:19.800
<v Speaker 2>And I guess the question is, why can't universities that

0:27:19.880 --> 0:27:24.639
<v Speaker 2>are charging incredibly high tuition, that run these massive investment

0:27:24.640 --> 0:27:28.240
<v Speaker 2>accounts and that also get donations, why can't they fund

0:27:28.280 --> 0:27:29.240
<v Speaker 2>everything themselves?

0:27:29.480 --> 0:27:31.760
<v Speaker 3>Okay, so first I just want to make a correction

0:27:31.880 --> 0:27:35.000
<v Speaker 3>that it's not profit margins. There's no profit here. It's

0:27:35.040 --> 0:27:38.720
<v Speaker 3>operating margins, right, It's the ability to keep your laboratory afloat.

0:27:39.440 --> 0:27:42.960
<v Speaker 3>So that said, endowments are not this sort of bucket

0:27:43.000 --> 0:27:48.080
<v Speaker 3>of free funds. Endowments are a collective of money that

0:27:48.400 --> 0:27:53.520
<v Speaker 3>has been donated by specific donors and earmarked for particular things,

0:27:53.920 --> 0:27:57.000
<v Speaker 3>and so there are legal requirements that you spend that

0:27:57.200 --> 0:27:59.679
<v Speaker 3>money on what the donor asks for it to be

0:27:59.720 --> 0:28:03.520
<v Speaker 3>spent on. There are a few places Johns Hopkins is

0:28:03.560 --> 0:28:07.520
<v Speaker 3>a great example. Bloomberg himself has made investments there that

0:28:07.560 --> 0:28:10.879
<v Speaker 3>can be spent directly on science. That's making a huge

0:28:10.880 --> 0:28:15.040
<v Speaker 3>difference there. But in general, at most universities, people who

0:28:15.119 --> 0:28:20.040
<v Speaker 3>are funding endowments are funding the sports stadium. Unfortunately, they're

0:28:20.160 --> 0:28:23.960
<v Speaker 3>funding financial aid, which is great. My own university has

0:28:23.960 --> 0:28:28.640
<v Speaker 3>made enormous strives in having an increase in Pelgramt eligible students,

0:28:28.760 --> 0:28:32.040
<v Speaker 3>which is super important. But for the most part, they're

0:28:32.080 --> 0:28:35.399
<v Speaker 3>not general funds that can be used to support anything

0:28:35.400 --> 0:28:35.879
<v Speaker 3>you want to.

0:28:36.280 --> 0:28:41.800
<v Speaker 1>Let's get back to operational realities. So some of your research. Recently,

0:28:42.240 --> 0:28:45.600
<v Speaker 1>I'm reading an article at Northwestern dot edu about lamp

0:28:45.640 --> 0:28:49.440
<v Speaker 1>pre eels, and obviously, as you mentioned, with the example

0:28:49.480 --> 0:28:52.800
<v Speaker 1>of ozempic and the Gila monster, you know what seems

0:28:52.920 --> 0:28:57.080
<v Speaker 1>like sort of pure lab experimentation in biology has the

0:28:57.080 --> 0:29:01.479
<v Speaker 1>potential to turn into an incredible profit. But even sitting

0:29:01.520 --> 0:29:04.560
<v Speaker 1>aside that question, Okay, let's say you have some new idea,

0:29:04.840 --> 0:29:08.320
<v Speaker 1>there's something new you want to explore about the biology

0:29:08.680 --> 0:29:12.360
<v Speaker 1>of eel and eel sells, et cetera. How do you

0:29:12.360 --> 0:29:14.960
<v Speaker 1>come up with the price you're applying for a grant

0:29:15.040 --> 0:29:17.840
<v Speaker 1>you want to build on some research that you do.

0:29:18.240 --> 0:29:21.920
<v Speaker 1>Talk to us just about that process of you think

0:29:21.960 --> 0:29:24.480
<v Speaker 1>you need or you feel you need X money, etc.

0:29:24.800 --> 0:29:27.440
<v Speaker 1>What do you do how do you blank sheet of paper,

0:29:27.760 --> 0:29:29.920
<v Speaker 1>you want to do a new experiment and you want

0:29:30.000 --> 0:29:32.600
<v Speaker 1>an IH money. What does that process look like of

0:29:32.600 --> 0:29:33.560
<v Speaker 1>coming up with that number?

0:29:34.000 --> 0:29:38.200
<v Speaker 3>Okay, so there's coming up with the ideas and coming

0:29:38.280 --> 0:29:41.160
<v Speaker 3>up with the grant numbers and budget it yourself. The

0:29:41.280 --> 0:29:45.120
<v Speaker 3>ideas usually stem from research that you've been doing and

0:29:45.560 --> 0:29:48.960
<v Speaker 3>are informed by research that other people are doing. It's

0:29:49.040 --> 0:29:52.400
<v Speaker 3>usually you will get into conversations with other researchers to

0:29:52.480 --> 0:29:55.120
<v Speaker 3>refine those ideas to really make them to the point

0:29:55.120 --> 0:29:58.760
<v Speaker 3>where they're shovel ready for actually doing experiments so you

0:29:58.760 --> 0:30:01.800
<v Speaker 3>can apply for grant funding for them. So the NIH

0:30:01.960 --> 0:30:06.320
<v Speaker 3>has two kinds of granting mechanisms going back since the

0:30:06.360 --> 0:30:09.920
<v Speaker 3>early two thousands. One is which has been the main

0:30:09.960 --> 0:30:13.280
<v Speaker 3>way that people get funding, is called modular grants. And

0:30:13.360 --> 0:30:16.120
<v Speaker 3>those grants are really a set amount of money, so

0:30:16.200 --> 0:30:20.560
<v Speaker 3>there's there's no sort of negotiating for what their actual

0:30:20.640 --> 0:30:23.400
<v Speaker 3>costs are. It's just that this is the amount of money,

0:30:23.680 --> 0:30:26.320
<v Speaker 3>and that amount of money has not changed in the

0:30:26.400 --> 0:30:31.120
<v Speaker 3>last twenty five years. And so while costs for personnel

0:30:31.280 --> 0:30:34.720
<v Speaker 3>and cost for reagents and everything else has gone up

0:30:35.160 --> 0:30:38.560
<v Speaker 3>a lot, that amount of grant money has not gone up.

0:30:38.640 --> 0:30:40.400
<v Speaker 1>What is are we talking one million?

0:30:40.400 --> 0:30:40.480
<v Speaker 4>Like?

0:30:40.480 --> 0:30:42.040
<v Speaker 1>What is a what is a money?

0:30:42.040 --> 0:30:43.920
<v Speaker 3>We're talking about two hundred and fifty thousand dollars a

0:30:44.000 --> 0:30:47.400
<v Speaker 3>yach ok Okay, So this is not a lot of money, right,

0:30:47.600 --> 0:30:50.680
<v Speaker 3>So if you want more money than that, and more

0:30:50.760 --> 0:30:53.640
<v Speaker 3>and more people are having to do this because two

0:30:53.680 --> 0:30:56.560
<v Speaker 3>hundred and fifty thousand dollars is not enough to support

0:30:56.560 --> 0:31:00.160
<v Speaker 3>a research laboratory anymore, then you have to submit a

0:31:00.280 --> 0:31:04.400
<v Speaker 3>non modular budget where you basically have to estimate in

0:31:04.520 --> 0:31:08.880
<v Speaker 3>excruciating detail how many personnel it needs and how much

0:31:08.960 --> 0:31:12.400
<v Speaker 3>that will cost. What are the actual animal costs, what

0:31:12.680 --> 0:31:16.720
<v Speaker 3>are the let's say sequencing costs for next generation sequencing,

0:31:16.760 --> 0:31:21.000
<v Speaker 3>genum sequencing, What are the reagent costs, etc. Do you

0:31:21.040 --> 0:31:24.320
<v Speaker 3>need any specialized pieces of equipment? Attach a quote for

0:31:24.400 --> 0:31:26.120
<v Speaker 3>me for that to show me exactly how much that

0:31:26.120 --> 0:31:28.760
<v Speaker 3>piece of equipment will cost. So this is non trivial.

0:31:29.240 --> 0:31:32.160
<v Speaker 3>You might argue, if you're looking for inefficiencies in the system,

0:31:32.400 --> 0:31:34.840
<v Speaker 3>that making people go into that much detail and then

0:31:34.880 --> 0:31:37.960
<v Speaker 3>needing people at the NIH to go into a forensic

0:31:38.080 --> 0:31:40.960
<v Speaker 3>dive onto each of those things is maybe not the

0:31:41.000 --> 0:31:43.280
<v Speaker 3>most efficient way of doing it, but it's the only

0:31:43.320 --> 0:31:45.560
<v Speaker 3>way of doing it right now, So it's not that

0:31:45.640 --> 0:31:47.920
<v Speaker 3>you're sort of pulling some number out of thin air

0:31:48.200 --> 0:31:50.240
<v Speaker 3>and saying, hey, dude, this is how much money I

0:31:50.480 --> 0:31:53.120
<v Speaker 3>need to do my research. It's going to get scrutinized.

0:31:53.200 --> 0:31:56.760
<v Speaker 3>At the university level. We actually have to submit even

0:31:56.800 --> 0:31:59.960
<v Speaker 3>more detailed budgets than will actually go into the NIA,

0:32:00.560 --> 0:32:02.600
<v Speaker 3>because they want to make sure that we are in

0:32:02.720 --> 0:32:04.800
<v Speaker 3>compliance so that we don't ever get in trouble with

0:32:04.840 --> 0:32:07.720
<v Speaker 3>the NIH. So I get asked for things internally that

0:32:07.920 --> 0:32:10.239
<v Speaker 3>are even beyond what NIH is going to ask for,

0:32:10.640 --> 0:32:13.000
<v Speaker 3>and then NIH will get those budgets and that will

0:32:13.000 --> 0:32:16.440
<v Speaker 3>get scrutinized before anything gets paid out. And it gets

0:32:16.440 --> 0:32:19.440
<v Speaker 3>scrutinized in two ways. It gets scrutinized during the grant

0:32:19.480 --> 0:32:22.320
<v Speaker 3>review process, where the reviewers are asked away in on

0:32:22.360 --> 0:32:24.560
<v Speaker 3>the budget and whether it's appropriate for the research that

0:32:24.760 --> 0:32:27.840
<v Speaker 3>is proposed. It will be scrutinized by the council, who

0:32:27.840 --> 0:32:31.040
<v Speaker 3>will do the same thing and who are increasingly, particularly

0:32:31.040 --> 0:32:34.600
<v Speaker 3>at the National Institutes of General Medical Sciences, are capping

0:32:34.640 --> 0:32:38.080
<v Speaker 3>the total amount of money that anyone investigator can have.

0:32:38.600 --> 0:32:41.400
<v Speaker 3>And it will get again scrutinized at the program officer

0:32:41.520 --> 0:32:43.640
<v Speaker 3>level before those grants are paid out.

0:32:44.440 --> 0:32:46.719
<v Speaker 2>I find this so interesting. How do you actually come

0:32:46.840 --> 0:32:49.640
<v Speaker 2>up with the estimate for some of the costs and

0:32:49.680 --> 0:32:53.080
<v Speaker 2>how does THEIAH actually go about evaluating whether or not

0:32:53.160 --> 0:32:57.080
<v Speaker 2>it's reasonable, because I think about with scientific research often

0:32:57.400 --> 0:33:00.320
<v Speaker 2>you're doing something very novel. So going back to the

0:33:00.360 --> 0:33:03.840
<v Speaker 2>Gila monster example, I mean, how do you know the

0:33:03.880 --> 0:33:08.560
<v Speaker 2>cost the reasonable cost of housing like two dozen deala

0:33:08.680 --> 0:33:11.480
<v Speaker 2>monsters for a few years while you experiment on them.

0:33:12.080 --> 0:33:14.280
<v Speaker 3>You have to do due diligence and figure it out,

0:33:14.480 --> 0:33:16.760
<v Speaker 3>and it does. It's time consuming. So a lot of

0:33:16.800 --> 0:33:20.360
<v Speaker 3>what faculty like me spend their time doing is deep

0:33:20.440 --> 0:33:24.240
<v Speaker 3>diving into these costs and keep diving into the accompanying

0:33:24.440 --> 0:33:28.160
<v Speaker 3>paperwork and administrative burden for lack of a better word,

0:33:28.360 --> 0:33:31.400
<v Speaker 3>that comes with a lot of these mechanisms, but it

0:33:31.520 --> 0:33:33.920
<v Speaker 3>is the only way to get the funding to do

0:33:33.960 --> 0:33:36.480
<v Speaker 3>the research. So if some things are easy. We know

0:33:36.560 --> 0:33:40.320
<v Speaker 3>in any given market what a competitive salary is for

0:33:40.600 --> 0:33:43.520
<v Speaker 3>a scientist at this level or that level, et cetera.

0:33:44.120 --> 0:33:47.440
<v Speaker 3>We know, at least at the beginning of the grant

0:33:47.640 --> 0:33:50.320
<v Speaker 3>what the costs for the reagents that we know that

0:33:50.320 --> 0:33:52.840
<v Speaker 3>we're going to need are. But You're right. As you

0:33:52.960 --> 0:33:56.200
<v Speaker 3>proceed in the grant, you may require a kind of

0:33:56.240 --> 0:33:59.880
<v Speaker 3>technology or kinds of reagents that you didn't initially budget for,

0:34:00.360 --> 0:34:03.920
<v Speaker 3>and that's when you're scrambling to find additional funds to

0:34:04.320 --> 0:34:05.840
<v Speaker 3>be able to do that, and that's where some of

0:34:05.920 --> 0:34:07.640
<v Speaker 3>these foundation graps sometimes come in.

0:34:08.120 --> 0:34:12.600
<v Speaker 1>I just have one last question. You know, obviously science

0:34:12.719 --> 0:34:15.800
<v Speaker 1>is a very broad category, but the thing that excites

0:34:15.800 --> 0:34:19.200
<v Speaker 1>people from a sort of commercial or return on public

0:34:19.280 --> 0:34:24.640
<v Speaker 1>spending investment perspective is the connection between science funding. Often

0:34:24.840 --> 0:34:28.160
<v Speaker 1>and it turned into a drug or a new therapy

0:34:28.560 --> 0:34:31.200
<v Speaker 1>of some sort. You mentioned to zempic and anti cancer

0:34:31.239 --> 0:34:34.680
<v Speaker 1>drugs and so forth. We've never like really done an

0:34:34.680 --> 0:34:38.640
<v Speaker 1>episode on the economics of labs in general, etc. And

0:34:38.719 --> 0:34:40.560
<v Speaker 1>I want to do way more on this because I

0:34:40.560 --> 0:34:43.120
<v Speaker 1>think it's really important. Can you sort of paint us

0:34:43.160 --> 0:34:47.440
<v Speaker 1>a general outline of in America right now, at the

0:34:47.440 --> 0:34:51.839
<v Speaker 1>source of original discovery, what is the distribution between sort

0:34:51.880 --> 0:34:55.280
<v Speaker 1>of what happens between the public sector versus a research

0:34:55.320 --> 0:34:57.840
<v Speaker 1>institution and then private sector labs.

0:34:58.600 --> 0:35:01.439
<v Speaker 3>Yeah, I mean since the nineteen fifties, this has been

0:35:01.680 --> 0:35:05.960
<v Speaker 3>an invaluable three way partnership. Right The government wants to

0:35:05.960 --> 0:35:09.000
<v Speaker 3>do research, but it knows that it doesn't have the capacity,

0:35:09.080 --> 0:35:11.920
<v Speaker 3>let's say, to do it all on the NIHS campus,

0:35:12.160 --> 0:35:16.359
<v Speaker 3>and so it partners with scientific laboratories at universities by

0:35:16.360 --> 0:35:19.439
<v Speaker 3>providing grant money so that basic research can be done.

0:35:20.320 --> 0:35:24.919
<v Speaker 3>The pharmaceutical industry or the biotechnology industry, they don't make

0:35:25.000 --> 0:35:27.960
<v Speaker 3>investments in that kind of foundational research because there's no

0:35:28.200 --> 0:35:30.920
<v Speaker 3>exact timeline for when you might get a payoff from that.

0:35:31.600 --> 0:35:34.719
<v Speaker 3>So what they do is look to the universities to

0:35:34.800 --> 0:35:38.000
<v Speaker 3>provide them with that foundational knowledge that then they can

0:35:38.320 --> 0:35:42.080
<v Speaker 3>make a startup company or take your promising results on

0:35:42.160 --> 0:35:44.720
<v Speaker 3>what could be a new drug and fund the clinical

0:35:44.760 --> 0:35:47.600
<v Speaker 3>trials that are going to see whether it's effective. And

0:35:47.719 --> 0:35:51.000
<v Speaker 3>this partnership has been incredibly successful and it is the

0:35:51.040 --> 0:35:55.320
<v Speaker 3>reason why the US is a leader in this area worldwide.

0:35:56.000 --> 0:35:57.960
<v Speaker 2>Just on this point, is there an argument to be

0:35:58.040 --> 0:36:02.840
<v Speaker 2>made that maybe universities could monetize some of their research better,

0:36:03.040 --> 0:36:06.880
<v Speaker 2>maybe have higher equity stakes or any equity stakes in

0:36:06.960 --> 0:36:10.800
<v Speaker 2>promising new drugs in exchange for the work they basically

0:36:10.840 --> 0:36:12.240
<v Speaker 2>do for big pharma.

0:36:12.960 --> 0:36:15.000
<v Speaker 3>Oh, you know, I think you could take that argument

0:36:15.040 --> 0:36:19.400
<v Speaker 3>even more broadly. So why is it that a drug

0:36:19.400 --> 0:36:21.600
<v Speaker 3>that was developed at Northwestern and there's a real example

0:36:21.640 --> 0:36:23.360
<v Speaker 3>for this, but i'll leave the drug in the person

0:36:23.400 --> 0:36:27.960
<v Speaker 3>out of it that was then turned into trillions of

0:36:28.040 --> 0:36:31.520
<v Speaker 3>dollars by a pharmaceutical company. Now the university did get

0:36:31.520 --> 0:36:33.359
<v Speaker 3>a cut of that because they had the patent on it.

0:36:33.560 --> 0:36:36.080
<v Speaker 3>But you know who isn't getting the benefits of it? You,

0:36:36.880 --> 0:36:39.960
<v Speaker 3>So you were getting charged huge amounts more money for

0:36:40.040 --> 0:36:43.600
<v Speaker 3>that same drug that was developed using US research funds

0:36:43.719 --> 0:36:46.399
<v Speaker 3>than someone in Europe. Is that, I think is where

0:36:46.400 --> 0:36:47.839
<v Speaker 3>the inefficiencies in the system were.

0:36:48.280 --> 0:36:49.759
<v Speaker 1>There's so much more I want to do on this.

0:36:49.840 --> 0:36:52.760
<v Speaker 1>Sometimes you read like a story about like some MIT

0:36:53.440 --> 0:36:56.680
<v Speaker 1>professor and somehow some biotecher was born out of his

0:36:56.760 --> 0:36:59.239
<v Speaker 1>labs and retires and is a billionaire, And I want

0:36:59.280 --> 0:37:02.239
<v Speaker 1>to understand more the economics of then how that was allocated.

0:37:02.560 --> 0:37:06.040
<v Speaker 1>But this was a fantastic introduction to the topic of

0:37:06.080 --> 0:37:08.919
<v Speaker 1>what's going on. So Carol Lebond, thank you so much

0:37:09.000 --> 0:37:11.560
<v Speaker 1>for coming on off lots happy to have talked with you.

0:37:11.600 --> 0:37:12.279
<v Speaker 3>Thank you very much.

0:37:12.680 --> 0:37:15.080
<v Speaker 2>Thanks Carol, that was great and I'd be happy.

0:37:14.840 --> 0:37:15.880
<v Speaker 3>To explain Lamprey to you.

0:37:15.960 --> 0:37:18.920
<v Speaker 2>At some point they frightened me. I think yea much

0:37:19.120 --> 0:37:21.359
<v Speaker 2>like I find them very interesting, but I also find

0:37:21.400 --> 0:37:22.920
<v Speaker 2>them extremely off putting.

0:37:22.960 --> 0:37:25.440
<v Speaker 3>At the same time, I'm convinced that they are the

0:37:25.600 --> 0:37:27.080
<v Speaker 3>inspiration for the Demi gorgan.

0:37:27.520 --> 0:37:29.160
<v Speaker 2>Oh yeah, you're right.

0:37:29.280 --> 0:37:32.719
<v Speaker 3>They look like that absolutely, But they are like a

0:37:33.000 --> 0:37:37.640
<v Speaker 3>living fossil. They are the closest thing we have to

0:37:38.320 --> 0:37:41.480
<v Speaker 3>a living example of what the most primitive vertebrate was.

0:37:41.560 --> 0:37:43.680
<v Speaker 3>And so if you want to understand where you, as

0:37:43.719 --> 0:37:46.960
<v Speaker 3>a human vertebrate comes from, we can look to evolutionary

0:37:47.000 --> 0:37:48.200
<v Speaker 3>studies using the lambrey.

0:37:48.480 --> 0:37:50.480
<v Speaker 1>Can we keep this last little bit? And that was

0:37:50.520 --> 0:37:51.240
<v Speaker 1>actually really.

0:37:51.080 --> 0:38:05.680
<v Speaker 5>Good, Thanks Carol, Thanks bye bye, Tracy.

0:38:05.719 --> 0:38:09.440
<v Speaker 1>I thought that was a really good introduction to the topic.

0:38:09.560 --> 0:38:14.560
<v Speaker 1>I will say this, like, I'm sure that someone could

0:38:14.600 --> 0:38:17.839
<v Speaker 1>walk in here and convince me, or at least make

0:38:17.880 --> 0:38:21.360
<v Speaker 1>a compelling argument that we need radical overhaul to the

0:38:21.640 --> 0:38:24.800
<v Speaker 1>NIH way we do drug discovery.

0:38:24.360 --> 0:38:26.480
<v Speaker 2>Or the way physcal shock therapy.

0:38:26.800 --> 0:38:29.440
<v Speaker 1>Yeah, or just that we really need to totally rethink

0:38:29.480 --> 0:38:32.719
<v Speaker 1>the way we do science investment in this country. I

0:38:33.040 --> 0:38:37.319
<v Speaker 1>also think that if the main lever you pull is

0:38:37.400 --> 0:38:40.440
<v Speaker 1>just less money, and it means that there are going

0:38:40.480 --> 0:38:42.640
<v Speaker 1>to be people who have worked for ten years and

0:38:42.680 --> 0:38:46.319
<v Speaker 1>then their career is derailed or various labs get shut

0:38:46.360 --> 0:38:49.279
<v Speaker 1>down or in a state of limbo that I'm very

0:38:49.320 --> 0:38:53.840
<v Speaker 1>skeptical that that alone would turn into better results.

0:38:54.040 --> 0:38:54.520
<v Speaker 5>Yeah.

0:38:54.560 --> 0:38:55.640
<v Speaker 1>Well, a couple things here.

0:38:55.719 --> 0:38:59.200
<v Speaker 2>So Number one, I liked your plea for billionaire researchers

0:38:59.239 --> 0:39:02.120
<v Speaker 2>to get in touch with thoughts, So I'll just repeat that.

0:39:02.360 --> 0:39:04.960
<v Speaker 2>If you are a researcher who has made tons of money,

0:39:05.120 --> 0:39:08.319
<v Speaker 2>yeah some invention, then please get in touch with us.

0:39:08.560 --> 0:39:10.960
<v Speaker 2>But secondly, I thought the point Carol made at the

0:39:11.080 --> 0:39:14.040
<v Speaker 2>very end of the podcast about how you know, a

0:39:14.040 --> 0:39:17.520
<v Speaker 2>lot of these discoveries, a lot of scientific advancement does

0:39:17.680 --> 0:39:23.319
<v Speaker 2>eventually get monetized, usually by private companies, even though it's

0:39:23.400 --> 0:39:27.839
<v Speaker 2>funded through public grants, And I think that's I mean

0:39:27.920 --> 0:39:31.160
<v Speaker 2>to her point like that is a huge area of inefficiency.

0:39:31.360 --> 0:39:35.680
<v Speaker 1>It's very easy to look around and find things you

0:39:35.760 --> 0:39:39.600
<v Speaker 1>don't like about any system, and there's too much paperwork,

0:39:39.960 --> 0:39:42.560
<v Speaker 1>or there are things that slow it down, and or

0:39:42.640 --> 0:39:45.840
<v Speaker 1>there is money that is going towards such a nebulous

0:39:45.880 --> 0:39:49.239
<v Speaker 1>area of science and you find some random example that

0:39:49.320 --> 0:39:53.000
<v Speaker 1>has no prospect of commercial application. I'm sure all of

0:39:53.040 --> 0:39:58.080
<v Speaker 1>that exists to an extent. It also seems objectively true

0:39:58.560 --> 0:40:01.320
<v Speaker 1>that at least at this moment in twenty twenty five,

0:40:01.960 --> 0:40:07.920
<v Speaker 1>the US has the world's most advanced pharmaceutical and biotech industry.

0:40:08.120 --> 0:40:10.560
<v Speaker 1>Could it be way better in some sort of like

0:40:10.680 --> 0:40:14.520
<v Speaker 1>alternate scenario where everything moved faster and more efficiently. It

0:40:14.600 --> 0:40:17.400
<v Speaker 1>seems plausible. But I think to Carol's point that I

0:40:17.440 --> 0:40:20.799
<v Speaker 1>really liked is that for the last several decades, the

0:40:20.920 --> 0:40:23.719
<v Speaker 1>US has really had the leading edge industry of the

0:40:23.719 --> 0:40:26.759
<v Speaker 1>world of studying the hard sciences, and those sciences have

0:40:26.880 --> 0:40:31.239
<v Speaker 1>turned into all these sort of commercialized technological breakthroughs. I

0:40:31.280 --> 0:40:35.360
<v Speaker 1>think people should appreciate what we have currently in this

0:40:35.480 --> 0:40:41.319
<v Speaker 1>country and understand the interplay between public money, research foundations

0:40:41.440 --> 0:40:45.719
<v Speaker 1>and commercial ventures that it put us at the technological frontier.

0:40:45.880 --> 0:40:45.920
<v Speaker 3>No.

0:40:46.239 --> 0:40:48.960
<v Speaker 2>Absolutely, And the one other thing I would add on

0:40:49.200 --> 0:40:53.120
<v Speaker 2>is I really like the Gila monster octhic example, because

0:40:53.360 --> 0:40:55.880
<v Speaker 2>this is something else that you see happen quite a

0:40:55.920 --> 0:40:58.960
<v Speaker 2>lot when people talk about research studies. So I think

0:40:58.960 --> 0:41:02.640
<v Speaker 2>Elon Musk has talked about like all these crazy scientific

0:41:02.719 --> 0:41:06.160
<v Speaker 2>projects like having shrimp run on treadmills and things like that,

0:41:06.719 --> 0:41:11.200
<v Speaker 2>but some of them actually lead to monetizable drugs, And

0:41:11.239 --> 0:41:14.360
<v Speaker 2>I think the shrimp example they were actually stress testing

0:41:14.880 --> 0:41:20.799
<v Speaker 2>marine animals or crustaceans ability to withstand environmental stresses. So

0:41:21.120 --> 0:41:25.200
<v Speaker 2>even if the projects sound very niche like with lampreys

0:41:25.280 --> 0:41:31.440
<v Speaker 2>or gila monsters, they can have interesting and potentially profitable consequences.

0:41:31.520 --> 0:41:34.520
<v Speaker 1>I'm never compelled, you know. People love to point out

0:41:34.520 --> 0:41:37.480
<v Speaker 1>areas of like, look at this, they spent one million

0:41:37.520 --> 0:41:40.160
<v Speaker 1>dollars to hold a really race among shrimp, you know,

0:41:40.400 --> 0:41:44.000
<v Speaker 1>or something like that. And I'm never compelled by I

0:41:44.080 --> 0:41:47.719
<v Speaker 1>believe that there exists government waste. There probably is even

0:41:47.760 --> 0:41:49.920
<v Speaker 1>a lot of it. I find those to be like

0:41:50.040 --> 0:41:55.480
<v Speaker 1>the least compelling. But it's not SPS. Maybe it's but

0:41:55.560 --> 0:41:57.640
<v Speaker 1>I but I do think we need to spend more

0:41:57.840 --> 0:41:59.720
<v Speaker 1>on shrimp doing relay races.

0:41:59.800 --> 0:42:03.480
<v Speaker 2>You know, It's funny whenever I hear guila monster. So

0:42:03.920 --> 0:42:08.200
<v Speaker 2>my dad, one of his best friends is called Gilah

0:42:08.440 --> 0:42:11.360
<v Speaker 2>and her husband is Dusty, and I always think that's

0:42:11.400 --> 0:42:14.960
<v Speaker 2>like the most Texan duo ever, Guila and Dusty.

0:42:15.280 --> 0:42:18.280
<v Speaker 1>Well that is, you know whatever, I always think about Guila,

0:42:18.760 --> 0:42:21.400
<v Speaker 1>although I see it's actually I was gonna say Guila

0:42:21.440 --> 0:42:23.960
<v Speaker 1>is one of the few words that was imported into

0:42:23.960 --> 0:42:28.080
<v Speaker 1>the US language from Southeast Asia. But actually in this case,

0:42:28.160 --> 0:42:30.680
<v Speaker 1>it is not. It has a totally different etymology. It

0:42:30.680 --> 0:42:33.120
<v Speaker 1>has something to do with the Southwest. So I thought

0:42:33.120 --> 0:42:34.200
<v Speaker 1>I knew something, but I don't.

0:42:34.320 --> 0:42:37.239
<v Speaker 5>Okay, shall we leave it there?

0:42:37.360 --> 0:42:38.120
<v Speaker 1>Let's leave it there.

0:42:38.320 --> 0:42:40.960
<v Speaker 2>This has been another episode of the All Thoughts podcast.

0:42:41.040 --> 0:42:44.480
<v Speaker 2>I'm Tracy Alloway. You can follow me at Tracy Alloway.

0:42:44.160 --> 0:42:46.920
<v Speaker 1>And I'm Jill Wisenthal. You can follow me at the Stalwart.

0:42:47.120 --> 0:42:50.720
<v Speaker 1>Follow our guest Carol Lebon, She's at Lebon Lab. Follow

0:42:50.760 --> 0:42:54.640
<v Speaker 1>our producers Carmen Rodriguez at Carmen Arman, dash, Ol Bennett

0:42:54.640 --> 0:42:57.759
<v Speaker 1>at Dashbott and Keil Brooks at Cale Brooks. For more

0:42:57.760 --> 0:43:00.600
<v Speaker 1>odd Lost content, go to Bloomberg dot com slash odd Lots.

0:43:00.680 --> 0:43:02.840
<v Speaker 1>We have a blog and a daily newsletter that you

0:43:02.920 --> 0:43:05.279
<v Speaker 1>can subscribe to. And if you want to chat about

0:43:05.320 --> 0:43:08.360
<v Speaker 1>all of these topics twenty four seven, including hard sciences

0:43:08.360 --> 0:43:11.680
<v Speaker 1>and pharma, go to our discord Discord dot gg slash

0:43:11.719 --> 0:43:12.200
<v Speaker 1>odd lots.

0:43:12.520 --> 0:43:15.120
<v Speaker 2>And if you enjoy odd Lots, if you like it

0:43:15.160 --> 0:43:19.480
<v Speaker 2>when we talk about scientific research funding and the etymology

0:43:19.719 --> 0:43:22.640
<v Speaker 2>of the word dela, then please leave us a positive

0:43:22.680 --> 0:43:26.200
<v Speaker 2>review on your favorite podcast platform. And remember, if you

0:43:26.280 --> 0:43:28.960
<v Speaker 2>are a Bloomberg subscriber, you can listen to all of

0:43:29.000 --> 0:43:32.160
<v Speaker 2>our episodes absolutely ad free. All you need to do

0:43:32.239 --> 0:43:35.360
<v Speaker 2>is find the Bloomberg channel on Apple Podcasts and follow

0:43:35.400 --> 0:44:00.960
<v Speaker 2>the instructions there. Thanks for listening. No